Related Experiment Video
Updated: Mar 16, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Impact of changed legislation on skin tests: the present and future
Ludger Klimek1, Hans Jürgen Hoffmann, Alexa Kugler
1aCenter for Rhinology and Allergology, Wiesbaden, Germany bDepartment of Clinical Medicine, Aarhus University, Aarhus C, Denmark cDepartment of Women and Child Health, Padua General University Hospital, Padua, Italy dDepartment of Otorhinolaryngology, University Hospitals Leuven, Leuven, Belgium eDepartment of Otorhinolaryngology, Academic Medical Centre Amsterdam, The Netherlands fDepartment of Respiratory Disease and Allergy, Aarhus University Hospital, Denmark.
Purpose Of Review:
To discuss the impact of current European Union regulations on the availability of commercially available skin test allergens in European member states.
Recent Findings:
European Union legislations now define diagnostic allergens to be medicine requiring market authorization of every individual diagnostic allergen with obligations including clinical trials, application dossiers, a regular update of the dossiers, handling of variation processes and ongoing stability testing of the source material and periodic safety update reporting. The financial expenses of the initiation and maintenance of approvals for diagnostic allergens far exceed their related revenues. Thus, the numbers of authorized test allergens are steadily decreasing.
Summary:
The current European Union regulations are anticipated to have an immense impact on in-vivo allergy diagnosis in Europe. Available skin test allergens decreased to less than half of what has been before in recent years. EAACI has addressed both the EU and EMA to resolve this situation.
More Related Videos
06:31Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
12:04Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices
Published on: May 9, 2018
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Drug Toxicity: Allergic Reactions
Toxicity Testing in Animals
FDA Approved Drugs: Changes to Approved Drugs
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...